GlassScriptPhysician profile
Alyssa P Heiderman
NPI 1740234137
$5,248.13
in general payments reported to CMS, 2019-2025
36 companies · $1,178 in 2025
The $1,178 reported for 2025 was more than what 87% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $627 · 2022: $1,174 · 2023: $1,200 · 2024: $1,069 · 2025: $1,178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,447.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $745.36 | 2021-2025 | Xtampza, Belbuca |
| Saluda Medical Americas, INC. | $532.21 | 2024-2025 | Evoke |
| Boston Scientific Corporation | $392.41 | 2022-2025 | Wavewriter Alpha Prime 16, Intracept |
| Abbott Laboratories | $371.04 | 2022-2025 | Eterna, Proclaim |
| Abbvie INC. | $321.74 | 2021-2024 | |
| Vertos Medical, INC. | $286.33 | 2022-2024 | Mild Device Kit |
| Averitas Pharma INC. | $269.40 | 2023-2025 | Qutenza |
| Pfizer INC. | $244.02 | 2021-2024 | |
| Grt US Holding, INC. | $235.28 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $224.77 | 2022-2025 | Relistor |
| Nevro Corp. | $173.26 | 2021-2024 | Senza |
| Teva Pharmaceuticals USA, INC. | $162.77 | 2021-2024 | Ajovy |
| Almatica Pharma LLC | $149.68 | 2021-2023 | Gralise |
| Protega Pharmaceutials INC | $148.83 | 2023-2024 | Roxybond |
| Tersera Therapeutics LLC | $97.38 | 2024-2025 | Prialt |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $91.04 | 2021 | |
| Mml US, INC. | $88.17 | 2023-2025 | Reactiv8 |
| Spr Therapeutics, INC | $87.70 | 2022-2025 | Sprint Pns System |
| Vertex Pharmaceuticals Incorporated | $74.86 | 2024-2025 | |
| Biotronik Nro, INC. | $73.84 | 2024-2025 | Prospera |
| Biohaven Pharmaceutical Holding Company LTD. | $66.52 | 2022 | |
| Medtronic, INC. | $63.77 | 2021-2025 | Inceptiv, Closurefast, Intellis Adaptivestim |
| Biohaven Pharmaceuticals, INC. | $55.53 | 2021 | |
| Redhill Biopharma INC. | $40.74 | 2021 | |
| Relievant Medsystems, INC. | $32.28 | 2023 | Intracept |
| Nalu Medical, INC. | $27.79 | 2023 | Nalu Neurostimulation System |
| Curonix LLC | $27.75 | 2022-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Globus Medical, INC. | $26.54 | 2025 | Senza |
| Tonix Medicines, INC. | $24.02 | 2025 | Tonmya |
| Ibsa Pharma INC. | $22.58 | 2023 | Tirosint, Licart |
| Spinal Simplicity, LLC | $21.75 | 2022 | |
| Valinor Pharma, LLC | $19.28 | 2025 | Movantik |
| Azurity Pharmaceuticals, INC. | $14.75 | 2023 | Horizant |
| Currax Pharmaceuticals LLC | $12.48 | 2022 | |
| Biodelivery Sciences International, INC. | $11.15 | 2021 | |
| Stimwave Technologies Incorporated | $11.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Heiderman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.